Lemaitre Vascular (LMAT) Tops Q1 EPS by 11c, provides guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.44, $0.11 better than the analyst estimate of $0.33. Revenue for the quarter came in at $53.5 million versus the consensus estimate of $49.77 million.

GUIDANCE:

Lemaitre Vascular sees Q2 2024 EPS of $0.45-$0.50, versus the consensus of $0.44. Lemaitre Vascular sees Q2 2024 revenue of $53.7-56.1 million, versus the consensus of $54.288 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c